Investing Ideas
/
Global High Growth Potential Companies

Global High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

8543

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

8,543 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
SKS SKS Technologies Group	AU$2.16	-4.8%	671.4%	AU$242.1m	AU$2.15	PE36.5x	E24.8%	0.5%	Capital Goods
MBTN Meyer Burger Technology	CHF 2.03	-16.0%	-97.6%	CHF 62.7m	CHF 6.03	PS0.7x	E109.3%	n/a	Semiconductors
AFISH Arctic Fish Holding	NOK 67.00	-2.2%	14.5%	NOK 2.1b	NOK 83.50	PE65.2x	E66.5%	n/a	Food, Beverage & Tobacco
INIT Initiator Pharma	SEK 7.20	2.9%	-16.3%	SEK 404.2m	SEK 22.50	PB16.7x	E31.7%	n/a	Pharmaceuticals & Biotech
ELABS Elliptic Laboratories	NOK 11.18	4.7%	-32.2%	NOK 1.2b	NOK 19.00	PS12.6x	E121.1%	n/a	Software
CADLR Cadeler	NOK 57.50	-2.5%	22.4%	NOK 20.2b	NOK 81.77	PE188.4x	E70.7%	n/a	Capital Goods
PHM Pharma Mar	€82.90	7.9%	101.2%	€1.4b	€84.40	PE2319.9x	E55.1%	0.8%	Pharmaceuticals & Biotech
9958 Century Iron and Steel IndustrialLtd	NT$160.50	3.5%	-26.0%	NT$41.2b	NT$238.00	PE19.6x	E44.9%	1.9%	Materials
2586 Dmall	HK$5.48	-5.5%	n/a	HK$4.9b	HK$8.50	PS2.6x	E88.4%	n/a	Software
WAYS Waystream Holding	SEK 15.80	1.5%	-41.5%	SEK 127.5m	SEK 36.50	PS1x	E113.3%	0%	Tech
NEWBRY Newbury Pharmaceuticals	SEK 3.56	1.7%	-25.1%	SEK 86.4m	SEK 8.00	PS2.3x	E130.0%	n/a	Pharmaceuticals & Biotech
ICOP I.CO.P.. Società Benefit	€7.80	-6.9%	n/a	€215.6m	€9.80	PE42.7x	E49.2%	n/a	Capital Goods
RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E	ج.م3.39	4.0%	80.8%	ج.م5.1b	ج.م5.02	PE19.2x	E30.7%	2.0%	Pharmaceuticals & Biotech
MVW M Vest Water	NOK 9.15	0.5%	6.4%	NOK 299.4m	NOK 11.70	PS15.6x	E71.7%	n/a	Materials
AGP Altea Green Power	€5.50	-10.3%	-39.8%	€95.2m	€12.85	PE14.1x	E22.1%	n/a	Capital Goods
ACE Ascelia Pharma	SEK 3.08	-3.4%	-69.3%	SEK 296.0m	SEK 8.25	PB2.8x	E47.2%	n/a	Pharmaceuticals & Biotech
RHM Rheinmetall	€733.60	6.9%	123.8%	€31.9b	€736.87	PE46.5x	E29.9%	0.8%	Capital Goods
FWRY Fawry for Banking Technology and Electronic PaymentsE	ج.م8.62	2.3%	58.5%	ج.م29.4b	ج.م12.45	PE23.7x	E27.4%	n/a	Diversified Financials
TGTX TG Therapeutics	US$29.04	-0.3%	81.7%	US$4.2b	US$41.00	PS15.7x	E43.9%	n/a	Pharmaceuticals & Biotech
PRL Propel Holdings	CA$40.59	17.8%	142.9%	CA$1.4b	CA$45.92	PE25.2x	E38.9%	1.5%	Diversified Financials
RCEL AVITA Medical	US$8.95	4.8%	-46.5%	US$224.1m	US$17.08	PS3.9x	E51.9%	n/a	Pharmaceuticals & Biotech
ARES Ares Management	US$195.90	4.3%	62.3%	US$60.7b	US$189.62	PE91.5x	E38.4%	1.9%	Diversified Financials
AXSM Axsome Therapeutics	US$103.89	10.9%	14.7%	US$5.0b	US$132.88	PS14.9x	E57.8%	n/a	Pharmaceuticals & Biotech
ALKT Alkami Technology	US$35.58	1.0%	45.3%	US$3.5b	US$45.10	PS11.3x	E102.7%	n/a	Software

Page 1 of 356